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Abstract
Aims
Reference laboratories advise immediate separation and freezing of samples for the assay
of proinsulin, which limit its practicability for smaller centres. Following the demonstration
that insulin and C-peptide are stable in EDTA at room temperature for at least 24hours, we
undertook simple stability studies to establish whether the same might apply to proinsulin.
Methods
Venous blood samples were drawn from six adult women, some fasting, some not, aliquoted
and assayed immediately and after storage at either 4˚C or ambient temperature for periods
from 2h to 24h.
Results
There was no significant variation or difference with storage time or storage condition in
either individual or group analysis.
Conclusion
Proinsulin appears to be stable at room temperature in EDTA for at least 24h. Immediate
separation and storage on ice of samples for proinsulin assay is not necessary, which will
simplify sample transport, particularly for multicentre trials.
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Introduction
Proinsulin is the prohormone of insulin, and is packaged in the beta cell by a ‘clip’ or connect-
ing C-peptide. The clip is shed by protease cleavage as the intact proinsulin molecule is
secreted, releasing equimolar quantities of C-peptide and active insulin into the circulation
[1]. In health, the majority of proinsulin is processed in this way, so that only small amounts of
intact proinsulin escape from the beta cell.
However, when stressed by the increased demand for insulin imposed by insulin resistance,
beta cells become progressively less able to cleave proinsulin,[2] as a result of which the circu-
lating concentration of intact proinsulin and the proinsulin:insulin ratio rises. Insulin resis-
tance is believed to underpin type 2 diabetes, and intact proinsulin has become an important
marker of metabolically stressed beta cells in both diabetes and prediabetes.[3]
Reference laboratories in the UK advise plain plastic (serum) or lithium heparin bottles
(plasma) for the collection of samples for proinsulin, with immediate freezing after separation
and transport on dry ice.[4] However, the same advice applied to the collection of samples for
insulin and C-peptide measurement, until a recent report in this journal from this laboratory
showed that both were stable, unseparated and at room temperature, for at least 24 hours–pro-
vided they were preserved in EDTA (ethylene-diamine-tetra-acetic acid) and not lithium hepa-
rin.[5] We wondered whether the same might apply to intact proinsulin, as it would simplify
sample transport considerably. Accordingly, we collected serum aliquots into EDTA bottles,
and measured proinsulin on several occasions over 24 hours to assess deterioration of the sam-
ple over time.
Samples and methods
Samples
Six healthy non-diabetic volunteers (all female), median age 36 years (range 27–53 years),
mean BMI 26.4 kg/m2 (range 22.5–31.3) provided samples for the study. Two of the subjects
were fasted, and the others post prandial, at the time of blood sampling.
The samples were excess clinical samples, anonymised before analysis, and used ethically in
line with the UK Human Tissue Authority’s directive on ‘Use of residual clinical material for
evaluation and assessment of in vitro diagnostic performance’ (Human Tissue Authority, code
of practice 9).[6] As an analysis of sample stability, the study was categorised as assay perfor-
mance analysis rather than clinical research.
Stability studies
Venous blood was collected from an ante-cubital vein of each of the volunteers and aliquoted
into twelve 3ml K+ EDTA BD Vacutainer tubes (BD Biosciences, Oxford, UK). Tubes were
inverted 10 times. Two of the aliquots were centrifuged immediately, while five were left as
whole blood to stand at room temperature (RT) and five at 4˚C. At each subsequent time point
(2, 6, 8, 12 and 24 hours), a further aliquot from each storage condition was centrifuged at
1300xg for 15 minutes at RT in a Beckman Coulter Allegra X-12 centrifuge (note tubes stored
at 4˚C were placed at RT 30 minutes before spin). From each, 160μl of plasma (upper layer)
were placed into a 3.5ml graduated storage vial (Elkay Labs, Basingstoke, UK) and stored at
-80˚C before being shipped frozen on dry ice to Exeter for batched analysis.
Analyses
Intact proinsulin was assayed using a commercial colorimetric two-site sandwich ELISA
(Teco, Switzerland) on a Dynex DS2 automated ELISA reader (Launch Diagnostics, Longfield,
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UK) giving an intra assay CV <2.4%, inter assay CV < 4% and a limit of detection of 0.3
pmol/L. The intact proinsulin assay is highly specific and has no cross reactivity with insulin,
C-peptide or either split and des forms of proinsulin. Proinsulin estimates in three of the 36
samples analysed in this study lay below the limit of detection, and were reported as 0.3 pmol/
l. Plasma insulin was measured using an electrochemiluminescence immunoassay on a Roche
E170 analyser (Roche Diagnostics, Mannheim, Germany) which has an intra assay CV<3.2%,
inter assay CV< 4.1% and a limit of detection of 3.0 pmol/L. The assay employed two mouse
monoclonal anti-insulin antibodies, the first labelled with acridinium ester, and the second
covalently coupled to paramagnetic particles. Both analyses were carried out at the Clinical
Chemistry Department of the Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Statistical presentation
Arithmetic means/±SDs are presented for proinsulin, insulin and proinsulin-insulin ratio at
each time point at both 4˚C and at room temperature. Subject-specific measures are plotted
for each variable under both conditions. Since individuals were measured repeatedly, a sepa-
rate linear mixed effect random intercept model was fitted to test whether the time-related lin-
ear trend at 4˚C was different than the trend at room temperature. The log-likelihood ratio test
statistic for model comparison showed significantly better fit in favour of random intercept
models compared to the single level regression model for all three outcomes (Proinsulin: X2
210.60, p<0.001; Insulin: X2 229.04, p<0.001; Proinsulin-insulin ratio: X2 230.69, p<0.001).
All outcomes were log transformed before fitting the model, and expected means/95% CI were
plotted after back transformation. Overall, 69 observations contributed to the model for proin-
sulin, 66 for insulin and 63 for proinsulin/insulin ratio.
Results
The range of proinsulin tested was 0.3–9.6 pmol/L, and that of insulin 60–190 pmol/L.
Within-subject variation (Fig 1) was small for all measures, suggesting that proinsulin and
insulin were stable in EDTA over time, whether at 4˚C or at room temperature. There were no
significant differences in the means and variance of the two conditions.
The group data in Fig 2 show the estimated means (back transformed) for all three out-
comes, and confirm how both intact proinsulin and insulin remained stable in whole blood at
4˚C and at room temperature for at least 24 hours in EDTA, and possibly for longer. The
mixed models showed no difference in trend over time when comparing the two conditions,
and the X2 tests of overall trends (time x condition interaction) were not statistically significant
at p = 0.08 (proinsulin), p = 0.12 (insulin) and p = 0.57 (proinsulin to insulin ratio).
Discussion
Reference laboratories and assay kit manufacturers advise that blood samples for the measure-
ment of intact proinsulin be processed immediately, and frozen for transport. This study
reported here suggests that, provided EDTA is used as the vehicle, proinsulin can be stored for
at least 24 hours at room temperature without the need for separation.
This laboratory showed previously that the same is true for insulin and C-peptide in
EDTA.5 Sample collection for proinsulin, like that of insulin, tends to be confined to larger
centres, not because of cost, but because of the logistics of centrifuging and freezing multiple
samples peripherally, and of putting them on dry ice for transport centrally. Our data indicate
that it is possible to store/transport whole blood in EDTA at room temperature for at least 24
hours, without fear of deterioration of intact proinsulin or insulin. The findings may have par-
ticular significance for multicentre trials, where smaller study sites lack the provision or
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personnel for sample separation/storage/specialised transport. Raw blood samples can now be
handed to a courier for same day transport to the study lab where separation, triage and label-
ling can all be carried out centrally without risk that the sample will spoil.
Conclusion
Pre-diabetes is increasingly recognised as a disease state, and proinsulin or the proinsulin:insu-
lin and proinsulin:C-peptide ratios as markers for it. Reference laboratories recommend
immediate separation and freezing of proinsulin samples, which makes their preparation, stor-
age and transport problematic. This report shows that proinsulin (as demonstrated recently
for insulin and C-peptide5) can be stored/transported unseparated at room temperature for at
least 24 hours in EDTA. Proinsulin can be dispatched as whole blood in EDTA without prepa-
ration, which will make it more available for both assay individuals and multicentre trials.
Fig 1. Individual data–within-subject variation in measures of proinsulin (upper panel), insulin (middle panel) and proinsulin:insulin ratio (lower
panel) at collection (0h) and at the five time points thereafter, in samples kept at 4˚C (left-hand panels) and at room temperature (right-hand
panels) for the duration.
https://doi.org/10.1371/journal.pone.0171716.g001
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